Knoll Capital Management, LP Buys Exicure Inc, Entera Bio, Abeona Therapeutics Inc, Sells Krystal Biotech Inc, Altria Group Inc, DuPont de Nemours Inc

• New Purchases: XCUR,
• Added Positions: ENTX, ABEO, CRBP, ALDX,
• Reduced Positions: DD,
• Sold Out: KRYS, MO, GLMD, ECOR, LPCN, VBLT,

For the details of Knoll Capital Management, LP's stock buys and sells, go to https://www.gurufocus.com/guru/knoll+capital+management%2C+lp/current-portfolio/portfolio

1. Biohaven Pharmaceutical Holding Co Ltd (BHVN) - 857,494 shares, 42.00% of the total portfolio.
2. Corbus Pharmaceuticals Holdings Inc (CRBP) - 5,045,870 shares, 24.81% of the total portfolio. Shares added by 1.20%
3. Abeona Therapeutics Inc (ABEO) - 2,859,767 shares, 8.42% of the total portfolio. Shares added by 21.19%
4. Eiger BioPharmaceuticals Inc (EIGR) - 350,238 shares, 4.70% of the total portfolio.
5. Exicure Inc (XCUR) - 1,277,777 shares, 3.29% of the total portfolio. New Position

Knoll Capital Management, LP initiated holding in Exicure Inc. The purchase prices were between $2.35 and $3.65, with an estimated average price of $2.73. The stock is now traded at around $2.38. The impact to a portfolio due to this purchase was 3.29%. The holding were 1,277,777 shares as of .

Knoll Capital Management, LP added to a holding in Entera Bio Ltd by 266.19%. The purchase prices were between $1.84 and $2.97, with an estimated average price of $2.3. The stock is now traded at around $3.15. The impact to a portfolio due to this purchase was 2.36%. The holding were 1,741,363 shares as of .

Knoll Capital Management, LP added to a holding in Abeona Therapeutics Inc by 21.19%. The purchase prices were between $2.17 and $5, with an estimated average price of $2.85. The stock is now traded at around $3.17. The impact to a portfolio due to this purchase was 1.47%. The holding were 2,859,767 shares as of .

Knoll Capital Management, LP sold out a holding in Krystal Biotech Inc. The sale prices were between $34.85 and $65.23, with an estimated average price of $49.63.

Knoll Capital Management, LP sold out a holding in Altria Group Inc. The sale prices were between $40.21 and $51.55, with an estimated average price of $47.35.

Knoll Capital Management, LP sold out a holding in Galmed Pharmaceuticals Ltd. The sale prices were between $3.61 and $6.75, with an estimated average price of $4.79.

Knoll Capital Management, LP sold out a holding in electroCore Inc. The sale prices were between $1.23 and $2.67, with an estimated average price of $1.69.

Knoll Capital Management, LP sold out a holding in Lipocine Inc. The sale prices were between $0.33 and $3.15, with an estimated average price of $1.45.

Knoll Capital Management, LP sold out a holding in Vascular Biogenics Ltd. The sale prices were between $1.1 and $1.32, with an estimated average price of $1.23.